Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 16/20 | 0.62 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.62 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.62 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.61 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4943019 | 0.87 | SLC9A1 (0.61) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL4944323 | 0.85 | ALDH1A1 (0.77) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL13078669 | 0.84 | SLC9A1 (0.63) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL12670456 | 0.83 | ALDH1A1 (0.68) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL15218327 | 0.81 | SLC9A1 (0.72) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL4942886 | 0.81 | ALDH1A1 (0.69) | S1PR4SLC9A1ALDH1A1MAPTNPSR1 | |
| SCHEMBL4941048 | 0.81 | SLC9A1 (0.69) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL4946224 | 0.81 | SLC9A1 (0.69) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL13044123 | 0.81 | S1PR4 (0.60) | S1PR4S1PR2S1PR3S1PR5SLC9A1 | |
| SCHEMBL21981938 | 0.78 | HTT (0.67) | ALDH1A1MAPTKDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7351843-B2 | Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-04-01 | — | — | US | disclosed |
| US-20070299131-A1 | Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2007-12-27 | — | — | US | disclosed |
| EP-1697335-A1 | FURANCARBONYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005063727-A1 | FURANCARBONYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2005-07-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299131-A1 | Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them | SLC9A1, NHERF1, SLC5A1 | S1PR4 2223/4885S1PR2 1396/4885S1PR3 1442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.